RIGL
Rigel Pharmaceuticals Inc
A South San Francisco biotechnology company that develops and sells prescription medicines for blood disorders and cancer. Its FDA-approved drugs include Tavalisse for immune thrombocytopenia (a low blood-platelet condition) and Rezlidhia for a form of acute myeloid leukemia. Founded in 1996, the company shares its name with Rigel, a brilliant blue star in the Orion constellation whose Arabic name means "the foot of the giant."
CUSIP: 766559603HealthcareUS1 holder
Total Value
$517.0K
Total Shares
151.1K
Net Share Change
+151.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
